Sirtex Surges After Co. Says Sirflox Study Results ‘Meaningful’

Shrs rise as much as 27%, most since May 14, vol. 18% of 3-mo. full-day avg.

  • Co. says Sirflox results confirmed meaningful, sees utilization
  • Study shows 7.9 month improvement in progress-free survival in liver cancer patients
  • NOTE: Prana +19%; European Commission approves PBT2 orphan designation for Huntington’s disease
  • 6 buys, 2 holds, 3 sells; avg PT A$27.52: Bloomberg data

Before it's here, it's on the Bloomberg Terminal. LEARN MORE